Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy

Abba E Leffler1, Evelyne M Houang1, Felicia Gray2

  • 1Schrödinger, Inc., New York, New York 10036, United States.

PubMed
Summary

Researchers found that targeting specific acidic residues (E906, E909) on the Son of Sevenless 1 protein (SOS1) with basic molecules significantly enhances inhibitor binding. This discovery offers a new strategy for developing potent SOS1 inhibitors for cancer therapy.

Related Concept Videos